Copy number variant and runs of homozygosity detection by microarrays enabled more precise molecular diagnoses in 11,020 clinical exome cases
Open Access
- 17 May 2019
- journal article
- research article
- Published by Springer Nature in Genome Medicine
- Vol. 11 (1) , 1-17
Abstract
Exome sequencing (ES) has been successfully applied in clinical detection of single nucleotide variants (SNVs) and small indels. However, identification of copy number variants (CNVs) using ES data remains challenging. The purpose of this study is to understand the contribution of CNVs and copy neutral runs of homozygosity (ROH) in molecular diagnosis of patients referred for ES. In a cohort of 11,020 consecutive ES patients, an Illumina SNP array analysis interrogating mostly coding SNPs was performed as a quality control (QC) measurement and for CNV/ROH detection. Among these patients, clinical chromosomal microarray analysis (CMA) was performed at Baylor Genetics (BG) on 3229 patients, either before, concurrently, or after ES. We retrospectively analyzed the findings from CMA and the QC array. The QC array can detect ~ 70% of pathogenic/likely pathogenic CNVs (PCNVs) detectable by CMA. Out of the 11,020 ES cases, the QC array identified PCNVs in 327 patients and uniparental disomy (UPD) disorder-related ROH in 10 patients. The overall PCNV/UPD detection rate was 5.9% in the 3229 ES patients who also had CMA at BG; PCNV/UPD detection rate was higher in concurrent ES and CMA than in ES with prior CMA (7.2% vs 4.6%). The PCNVs/UPD contributed to the molecular diagnoses in 17.4% (189/1089) of molecularly diagnosed ES cases with CMA and were estimated to contribute in 10.6% of all molecularly diagnosed ES cases. Dual diagnoses with both PCNVs and SNVs were detected in 38 patients. PCNVs affecting single recessive disorder genes in a compound heterozygous state with SNVs were detected in 4 patients, and homozygous deletions (mostly exonic deletions) were detected in 17 patients. A higher PCNV detection rate was observed for patients with syndromic phenotypes and/or cardiovascular abnormalities. Our clinical genomics study demonstrates that detection of PCNV/UPD through the QC array or CMA increases ES diagnostic rate, provides more precise molecular diagnosis for dominant as well as recessive traits, and enables more complete genetic diagnoses in patients with dual or multiple molecular diagnoses. Concurrent ES and CMA using an array with exonic coverage for disease genes enables most effective detection of both CNVs and SNVs and therefore is recommended especially in time-sensitive clinical situations.Keywords
Funding Information
- Foundation for the National Institutes of Health (R35NS105078, UM1 HG006542, HG008986)
This publication has 46 references indexed in Scilit:
- Phenotypic heterogeneity of ZMPSTE24 deficiencyAmerican Journal of Medical Genetics Part A, 2018
- Use of Exome Sequencing for Infants in Intensive Care UnitsJAMA Pediatrics, 2017
- Dual molecular diagnosis contributes to atypical Prader–Willi phenotype in monozygotic twinsAmerican Journal of Medical Genetics Part A, 2017
- Whole-Genome Sequencing of Cytogenetically Balanced Chromosome Translocations Identifies Potentially Pathological Gene Disruptions and Highlights the Importance of Microhomology in the Mechanism of FormationHuman Mutation, 2016
- CRIPT exonic deletion and a novel missense mutation in a female with short stature, dysmorphic features, microcephaly, and pigmentary abnormalitiesAmerican Journal of Medical Genetics Part A, 2016
- Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum DisorderJAMA, 2015
- Molecular Findings Among Patients Referred for Clinical Whole-Exome SequencingJAMA, 2014
- Genetic counseling for susceptibility loci and neurodevelopmental disorders: The del15q11.2 as an exampleAmerican Journal of Medical Genetics Part A, 2013
- Dissecting the genotype in syndromic intellectual disability using whole exome sequencing in addition to genome-wide copy number analysisHuman Genetics, 2013
- Detection of clinically relevant exonic copy-number changes by array CGHHuman Mutation, 2010